Related Experiment Video
Updated: Jun 19, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk
Angela Hsu1, Andrea Card, Susan Xiaoqin Lin
1Columbia Presbyterian Medical Center, New York, NY 10032, USA.
Abstract:
After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P<.001) among women with CVD versus 3% (from 19.8 to 16.8%; P=.68) among low-risk women, suggesting that most of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Menopause
Atherosclerosis III: Management
Heart Failure Drugs: β-Blockers
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy V: Interprofessional Care
